SDS–PAGE gels confirming the preparation of 40 kDa PEG conjugated trastuzumab and Alexa488 labeled PEG–trastuzumab and trastuzumab. Comparison between plasma concentrations of PEG–trastuzumab in non ...

Rie Natsume and her collaborators have recently developed an innovative and cost-effective method for generating rats that ...

An ultrathin implant that delivers stimulation directly to the spinal cord significantly improved motion and sensation in injured rats ...

By comparison, they found that it took only nine hours for blood glucose levels to return to their original values in control models treated with insulin by the normal route of subcutaneous injection.

A study by researchers at Rutgers Health has uncovered a way to precisely identify and target trauma sites in the body within ...

What motivated the man to try self-administered semen injection as a cure for back pain? What if you try to fix a nagging ...

Panelists discuss how integrating subcutaneous (SubQ) therapies into oncology practice involves thorough economic evaluation, ...

Over the past decade, several novel immunotherapies have transformed the treatment landscape of relapsed or refractory B-cell acute lymphoblastic leukaemia. In the pivotal TOWER trial, blinatumomab—a ...

BrightGene Pharmaceutical Co., Ltd., an international, innovation-driven pharmaceutical company, presented data from two Phase 2 studies for BGM0504, its ...

Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that ...

AMSTERDAM, The Netherlands I June 20, 2025 I argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, ...

SAN DIEGO - Halozyme Therapeutics, Inc. (NASDAQ: HALO), a $6.5 billion biotech company with exceptional financial health according to InvestingPro metrics, announced today that argenx has received ...